ARLINGTON, Va. — NACDS on Monday expressed appreciation for a new federal rule that will help to reduce seniors’ out-of-pocket prescription drug costs by improving transparency of exorbitant direct and indirect remuneration (DIR) fees imposed by payers on pharmacies. NACDS insists that comprehensive DIR fee reform now depends on further legislative and regulatory action to
ALEXANDRIA, Va. – Hundreds of organizations representing community pharmacies, grocery store pharmacies, specialty pharmacies, chain pharmacies, patient groups, buying groups, health systems, wholesalers, and business groups are making an all-out push for legislation that would stop the abuse of pharmacy price concessions charged by third-party middlemen, which have increased 91,500% in recent years. The Pharmacy
ALEXANDRIA, Va. — Hundreds of organizations representing community pharmacies, grocery store pharmacies, specialty pharmacies, chain pharmacies, patient groups, buying groups, health systems, wholesalers, and business groups are making an all-out push for legislation that would stop the abuse of pharmacy price concessions charged by third-party middlemen, which have increased 91,500% in recent years. The Pharmacy
WASHINGTON — With the Senate Finance Committee expected to begin making decisions on spending bills as early as today, the National Association of Chain Drug Stores has launched a telephone hotline — (866) DIR-RE4M — that pharmacy advocates can use to urge the inclusion of DIR fee relief in drug-pricing legislation. An NACDS RxImpact grassroots
WASHINGTON — Action by the Trump Administration, Congress or both is needed now to provide relief from pharmacy direct and indirect remuneration (DIR) fees that inflate drug costs paid by patients and the government, and that force pharmacies to fill Medicare prescriptions often below cost. That was the message delivered Monday in a letter to
The community pharmacy profession was blindsided by the Trump administration last month when the Department of Health and Human Services issued the final rule that will govern the Medicare Part D and Medicare Advantage programs in 2020. In a radical departure from the proposed rule released earlier in the year, the eventual regulation offered no
ARLINGTON, Va. – The National Association of Chain Drug Stores (NACDS) RxIMPACT grassroots advocacy program has mobilized to support a U.S. Senate initiative urging action by U.S. Secretary of Health and Human Services Secretary Alex Azar on direct and indirect remuneration (DIR) fee reform in Medicare Part D. NACDS RxIMPACT pharmacy advocates are urging Senators to
